- Home
- NERV vs RETO Comparison
NERV vs RETO Comparison
Compare NERV & RETO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NERV
- RETO
- Stock Information
- Founded
- NERV 2007
- RETO 1999
- Country
- NERV United States
- RETO China
- Employees
- NERV N/A
- RETO N/A
- Industry
- NERV Biotechnology: Pharmaceutical Preparations
- RETO Multi-Sector Companies
- Sector
- NERV Health Care
- RETO Consumer Discretionary
- Exchange
- NERV Nasdaq
- RETO Nasdaq
- Market Cap
- NERV 12.4M
- RETO 10.0M
- IPO Year
- NERV 2014
- RETO 2017
- Fundamental
- Price
- NERV $1.59
- RETO $3.22
- Analyst Decision
- NERV Hold
- RETO
- Analyst Count
- NERV 1
- RETO 0
- Target Price
- NERV $5.00
- RETO N/A
- AVG Volume (30 Days)
- NERV 7.7K
- RETO 384.3K
- Earning Date
- NERV 05-20-2025
- RETO 06-26-2025
- Dividend Yield
- NERV N/A
- RETO N/A
- EPS Growth
- NERV N/A
- RETO N/A
- EPS
- NERV 0.19
- RETO N/A
- Revenue
- NERV N/A
- RETO $3,841,142.00
- Revenue This Year
- NERV N/A
- RETO N/A
- Revenue Next Year
- NERV N/A
- RETO N/A
- P/E Ratio
- NERV $8.42
- RETO N/A
- Revenue Growth
- NERV N/A
- RETO N/A
- 52 Week Low
- NERV $1.15
- RETO $0.33
- 52 Week High
- NERV $3.69
- RETO $7.10
- Technical
- Relative Strength Index (RSI)
- NERV 46.58
- RETO 48.97
- Support Level
- NERV $1.65
- RETO $3.02
- Resistance Level
- NERV $1.75
- RETO $4.10
- Average True Range (ATR)
- NERV 0.08
- RETO 0.53
- MACD
- NERV -0.00
- RETO -0.05
- Stochastic Oscillator
- NERV 31.03
- RETO 12.00
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About RETO ReTo Eco-Solutions Inc.
ReTo Eco-Solutions Inc is a manufacturer and distributor of eco-friendly construction materials and fly-ash, as well as equipment used to produce these eco-friendly construction materials. The company engaged in providing consultation, design, project implementation and construction of urban ecological environments for capturing, controlling and re-using rainwater. It operates through four segments namely Machinery and Equipment sales, Construction materials sales, Municipal Construction Projects, and Technology Consulting and other services. The company earns its revenue from Machinery and Equipment sales segment. Geographically, it derives a majority of its revenue from China.